Creo Medical Group (LON:CREO) Trading 0.4% Higher – Time to Buy?

Creo Medical Group PLC (LON:CREO) rose 0.4% during trading on Tuesday . The stock traded as high as GBX 10.07 and last traded at GBX 10.07. Approximately 215,456 shares traded hands during trading, a decline of 78% from the average daily volume of 988,703 shares. The stock had previously closed at GBX 10.03.

Creo Medical Group Price Performance

The business has a fifty day moving average of GBX 10.72 and a two-hundred day moving average of GBX 12.33. The company has a debt-to-equity ratio of 29.96, a quick ratio of 2.19 and a current ratio of 3.24. The firm has a market capitalization of £41.52 million, a price-to-earnings ratio of -10.07 and a beta of 0.86.

Creo Medical Group (LON:CREO) last released its quarterly earnings data on Monday, September 22nd. The company reported GBX 4 EPS for the quarter. Creo Medical Group had a negative net margin of 73.93% and a negative return on equity of 41.79%. As a group, research analysts predict that Creo Medical Group PLC will post -10.0800005 EPS for the current fiscal year.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.